The SPARC Score: A Multifactorial Outcome Prediction Model for Patients Undergoing Radical Cystectomy for Bladder Cancer

医学 膀胱切除术 膀胱癌 结果(博弈论) 泌尿科 前列腺癌 前列腺切除术 肿瘤科 内科学 癌症 数学 数理经济学
作者
Manuel S. Eisenberg,Stephen A. Boorjian,John C. Cheville,R. Houston Thompson,Prabin Thapa,Dharam Kaushik,Igor Frank
出处
期刊:The Journal of Urology [Lippincott Williams & Wilkins]
卷期号:190 (6): 2005-2010 被引量:62
标识
DOI:10.1016/j.juro.2013.06.022
摘要

While multiple independent clinicopathological variables are associated with the outcome of radical cystectomy for bladder cancer, limited prediction tools exist to facilitate individualized risk assessment. We developed the SPARC (Survival Prediction After Radical Cystectomy) score, a prediction model for bladder cancer specific survival after radical cystectomy.We evaluated 2,403 patients who underwent radical cystectomy without neoadjuvant therapy at our institution between 1980 and 2008 with pathological re-review of all specimens. Of these patients 1,776 with nonmetastatic urothelial carcinoma were identified for analysis. A multivariate model was developed using stepwise selection to determine variables associated with cancer specific survival. We created a scoring system based on the β coefficients of this model.Median followup after radical cystectomy in patients alive at last followup was 10.5 years (IQR 7.3, 15.3), during which time 610 had died of bladder cancer. In addition to pathological tumor stage, nodal status, multifocality and lymphovascular invasion, the patient specific factors of Charlson comorbidity index, Eastern Cooperative Oncology Group (ECOG) performance status, current smoking, preoperative hydronephrosis and receipt of adjuvant chemotherapy were significantly associated with the risk of bladder cancer death. We used cumulative scores of these variables to stratify patients into risk groups with 95%, 80%, 60%, 38% and 23% 5-year cancer specific survival from the lowest to the highest risk group, respectively (p<0.0001). The concordance index of this model was 0.75.We present a model to individualize the estimation of cancer specific survival after radical cystectomy. Pending external validation, these data may be used for patient counseling, specifically in regard to recommendations for adjuvant therapy and surveillance frequency, as well as for clinical trial development.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
CL完成签到 ,获得积分10
2秒前
3秒前
8秒前
11秒前
12秒前
段远凯发布了新的文献求助50
13秒前
CHEN完成签到,获得积分10
15秒前
15秒前
大明完成签到 ,获得积分10
16秒前
16秒前
ira发布了新的文献求助10
17秒前
cdercder应助科研通管家采纳,获得10
24秒前
26秒前
ZHANG完成签到 ,获得积分10
35秒前
Fern完成签到 ,获得积分10
37秒前
50秒前
Boris完成签到 ,获得积分10
52秒前
baolipao完成签到,获得积分10
53秒前
oyfff完成签到 ,获得积分10
56秒前
Jasper应助含蓄的芾采纳,获得10
58秒前
oscar完成签到,获得积分10
58秒前
kkk完成签到 ,获得积分10
59秒前
含蓄的芾完成签到,获得积分10
1分钟前
柴yuki完成签到 ,获得积分10
1分钟前
1分钟前
屠夫9441完成签到 ,获得积分10
1分钟前
lalalal完成签到 ,获得积分10
1分钟前
racill完成签到 ,获得积分10
1分钟前
残幻应助wangyt采纳,获得10
1分钟前
1分钟前
郭mm完成签到 ,获得积分10
1分钟前
筱煜发布了新的文献求助10
1分钟前
yi完成签到 ,获得积分10
1分钟前
不着四六的岁月完成签到,获得积分10
1分钟前
liang19640908完成签到 ,获得积分10
1分钟前
1分钟前
FashionBoy应助筱煜采纳,获得10
1分钟前
逆流的鱼完成签到 ,获得积分10
1分钟前
GDMU完成签到,获得积分10
1分钟前
寒战完成签到 ,获得积分10
2分钟前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
the MD Anderson Surgical Oncology Manual, Seventh Edition 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3777640
求助须知:如何正确求助?哪些是违规求助? 3323099
关于积分的说明 10212929
捐赠科研通 3038447
什么是DOI,文献DOI怎么找? 1667372
邀请新用户注册赠送积分活动 798115
科研通“疑难数据库(出版商)”最低求助积分说明 758237